SEER update of incidence and trends in pediatric malignancies:: Acute lymphoblastic leukemia

被引:82
作者
McNeil, DE
Coté, TR
Clegg, L
Mauer, A
机构
[1] NCI, Div Canc Epidemiol & Genet, Genet Epidemiol Branch, Rockville, MD USA
[2] NCI, Div Canc Control & Populat Sci, Canc Stat Branch, Rockville, MD USA
[3] Univ Tennessee, Div Hematol Oncol, Memphis, TN USA
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 2002年 / 39卷 / 06期
关键词
acute lymphoblastic leukemia (ALL); epidemiology; SEER;
D O I
10.1002/mpo.10161
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background. Acute lymphoblastic leukemia (ALL) represents the most common malignancy of childhood. its incidence peaks in children just before school entry age; i.e., in 2-3 year olds. It is known to be more common in white children in the USA; the incidence is also higher in boys than girls. Procedure. We reviewed the 5,379 cases of ALL among persons under 20 years of age in the National Cancer Institute's Surveillance Epidemiology and End Results SEER) database. Results. The overall incidence of ALL was 26/10(6) person-years between 1973 and 1998, but increased from 19/10(6) person-years in 1973-77 to 28/10(6) person-years in 1993-98 P < 0.0001). Rates were 44% higher among Whites compared to Blacks (27/10(6) person-years vs. 15/10(6) person-years, P < 0.0001). In 1992-1998, the incidence rate for Hispanics was 43/10(6) person-year, significantly higher than non-Hispanics (28/10(6), P < 0.0001). White children with ALL had better 5-year survival rates than Black children with ALL (71% vs. 58%, P < 0.0001), and 5-year surival was poorest among black males. Conclusions. ALL incidence has increased over the examined 25-year period. The rate in US whites is higher than that of US Blacks, mid the rates in the Hispanic subgroup are the highest of all. While the median survival period is now more than 10 years overall, the 5-year survival rate remains poor for Black males under 4 guar, of age. Socioeconomic factors do not account for this difference, which may relate to ALL subtype distribution. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:554 / 557
页数:4
相关论文
共 21 条
[1]
ALTMAN AJ, 1990, AM J PEDIAT HEMATOL, V12, P123
[2]
*DCCPS SURV RES PR, 2000, SURV EP END RES SEER
[3]
GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO
[4]
2-F
[5]
HULTSTROM D, 2001, STANDARDS CANC REGIS, V2
[6]
CLINICAL RELEVANCE OF LYMPHOBLAST BIOLOGICAL FEATURES IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
KALWINSKY, DK ;
ROBERSON, P ;
DAHL, G ;
HARBER, J ;
RIVERA, G ;
BOWMAN, WP ;
PUI, CH ;
OCHS, J ;
ABROMOWITCH, M ;
COSTLOW, ME ;
MELVIN, SL ;
STASS, S ;
WILLIAMS, DL ;
MURPHY, SB .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (04) :477-484
[7]
Margolin Judith F., 1997, P409
[8]
National Center for Health Statistics, NAT DEATH IND
[9]
Percy C., 1990, International Classification of Diseases for Oncology, V2nd
[10]
ASYMPTOTICALLY EFFICIENT RANK INVARIANT TEST PROCEDURES [J].
PETO, R ;
PETO, J .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1972, 135 :185-&